Dr Mathias Lidgren

43 years old. Represents interests of Limea Ltd., the controlling shareholder. Practising medical doctor since 2013. Worked for NHS United Kingdom, Hôpitaux Universitaires de Genève (Geneva, Switzerland), and Sahlgrenska University Hospital (Gothenburg, Sweden). Until June 2024, practised at Skane University Hospitals in Lund, Sweden, and was post-doctoral researcher in Division of Molecular Medicine and Gene Therapy at Lund University. Board-certified specialist in clinical genetics in Sweden. Holds directorships in Swedish companies including Propatria AB, Rotationsplast i Munka-Ljungby AB, Caithness Fastighets AB, Forvaltningsaktiebolaget Maple, Trolleholms Slott AB, and Captiosus AB. Chief Medical Officer of Moroxite T AB.